Michael del Prado
Net worth: 105 039 $ as of 2026-05-30
Net worth: 105 039 $ as of 2026-05-30
Michael del Prado currently works at Cochlear Ltd., as Independent Non-Executive Director from 2022 and Ambu A, as Independent Director from 2021.
Mr. del Prado also formerly worked at Ethicon, Inc., as Group Chairman from 2013 to 2018, Johnson & Johnson Medical Devices & Diagnostics Group, as Chairman from 2009 to 2012, and Verb Surgical, Inc., as Director.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-08-27 | 1,016 ( 0% ) | 73 467 $ | 2026-05-30 | |
| 2025-09-29 | 3,000 ( 0% ) | 31 573 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| AMBU A/S | Director/Board Member | 2021-12-13 |
| COCHLEAR LIMITED | Director/Board Member | 2021-12-31 |
| Companies | Position | End |
|---|---|---|
Ethicon, Inc.
Ethicon, Inc. Medical SpecialtiesHealth Technology Develops and markets medical products and devices for surgery | Chairman | 2018-11-30 |
Johnson & Johnson Medical Devices & Diagnostics Group | Chairman | 2012-11-30 |
Verb Surgical, Inc.
Verb Surgical, Inc. Medical SpecialtiesHealth Technology Designs and manufactures surgical equipment | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Cochlear Ltd.
Cochlear Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and markets implantable hearing solutions | Health Technology |
Ambu A/S
Ambu A/S Medical SpecialtiesHealth Technology Manufactures and markets diagnostic and life supporting devices for hospitals | Health Technology |
Ethicon, Inc.
Ethicon, Inc. Medical SpecialtiesHealth Technology Develops and markets medical products and devices for surgery | Health Technology |
Verb Surgical, Inc.
Verb Surgical, Inc. Medical SpecialtiesHealth Technology Designs and manufactures surgical equipment | Health Technology |
Johnson & Johnson Medical Devices & Diagnostics Group |
Select your edition
All financial news and data tailored to specific country editions